SCHEMBL737292

SCHEMBL737292

O=c1[nH]c2cccnc2n1CCN1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.48
HTR7 P34969 1/20 0.48
TLR9 Q9NR96 3/20 0.47
CNR1 P21554 4/20 0.44
CNR2 P34972 4/20 0.44
GAA P10253 2/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL739228 0.79 HTR7 (0.73) HTR7ALDH1A1CYP3A4CYP2C9SMN1; SMN2
SCHEMBL891521 0.79 DAO (0.55) DAOKDM4EALDH1A1POLBSMN1; SMN2
SCHEMBL11157925 0.78 GRIN1 (0.45) CTDSP1TLR9CNR1CNR2KDM4E
SCHEMBL10479207 0.78 P2RX7 (0.65) HTR7
Hydrochloric Acid SCHEMBL9725420 0.78 HTR7 (0.71) HTR7ALDH1A1CYP3A4CYP2C9SMN1; SMN2
SCHEMBL737783 0.77 CTDSP1 (0.53) CTDSP1TLR9GAAKDM4EHSD17B10
Hydrochloric Acid SCHEMBL10479206 0.76 DAO (0.53) DAOKDM4EHSD17B10ALDH1A1POLB
SCHEMBL10479214 0.76 ALDH1A1 (0.61) DAOKDM4EHSD17B10ALDH1A1POLB
SCHEMBL9589251 0.76 KDM4E (0.52) CNR1CNR2GAAKDM4EALDH1A1
SCHEMBL11230940 0.75 CTDSP1 (0.46) CTDSP1TLR9GAAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138177-B2 Benzimidazolone derivatives as CB2 receptor ligands PFIZER INC. (US) 2012-03-20 US disclosed
EP-1861377-B1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS PFIZER (US) 2010-12-29 EP disclosed
US-20090298811-A1 BENZIMIDAZOLONE DERIVATIVES PFIZER INC 2009-12-03 US disclosed
US-20090181957-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS ANDO KAZUO 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298811-A1 BENZIMIDAZOLONE DERIVATIVES TRPV1, CNR1, CNR2 DAO 4401/4885CTDSP1 2735/4885HTR7 209/4885
US-20090181957-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS TRPV1, CNR1, CNR2 DAO 4549/4885CTDSP1 3426/4885HTR7 335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.